IKT Operating Expenses

Inhibikase Therapeutics Inc · Operating Expenses

IKT logo

IKT Operating Expenses

Latest reported$65.81M
IKT TTM Operating Expenses ($3.74M → $65.81M)
High-resolution chart · PNG

IKT operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Inhibikase Therapeutics Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
65,810,267
55,591,550
51,974,283
51,120,790
44,179,893
38,398,150
28,575,936
20,050,802
19,065,203
20,174,275
20,172,910
20,169,409
19,846,241
15,350,942
12,246,151
9,505,800
6,632,037
6,576,701
6,507,641
5,998,813
4,934,687
3,696,046
2,623,158
1,873,463
2,497,249
4,465,530
5,670,509
7,880,034
6,894,403
5,299,278
3,736,394
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.